Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Sheinfeld

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2019
Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell TumorsSamuel A Funt, Sujata Patil, Darren R Feldman, et al.
Urology|December 7, 2025
Can Novel Biomarkers Augment Traditional Surveillance Paradigms in Early-stage Testicular Germ Cell Tumors? A Case Study in Pre-clinical Relapse Detection Using a Combination Micro-RNA-371a-3p and 372-3p AssayJonathan Huynh, Adam Levin, Vincent D'Andrea, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 19, 2015
Follow-Up Management of Patients With Testicular Cancer: A Multidisciplinary Consensus-Based ApproachClair J Beard, Shilpa Gupta, Robert J Motzer, et al.
Investigational New Drugs|May 24, 2007
Phase II trial of ixabepilone in patients with cisplatin-refractory germ cell tumorsDarren R Feldman, G Varuni Kondagunta, Michelle S Ginsberg, et al.
European Urology Open Science|August 18, 2025
Pathologic and Oncologic Outcomes of Patients Undergoing Orchiectomy After Chemotherapy for Advanced Testicular Germ Cell TumorsViranda H Jayalath, Fady Baky, Samuel A Gold, et al.
Cancer|April 23, 2013
Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and olderDarren R Feldman, Martin H Voss, Erin P Jacobsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysisDarren R Feldman, Joel Sheinfeld, Dean F Bajorin, et al.
Urology|August 11, 2024
Long-term Outcomes of Regressed or "Burnt Out" Primary Testicular Germ Cell TumorsFady J Baky, Nicole Liso, Brandon Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2006
Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumorsG Varuni Kondagunta, Jennifer Bacik, Joel Sheinfeld, et al.
Urology|February 8, 2018
Clinical Outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy SpecimenCatherine M Dowling, Melissa Assel, John E Musser, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2019
Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell TumorsSamuel A Funt, Sujata Patil, Darren R Feldman, et al.
Urology|December 7, 2025
Can Novel Biomarkers Augment Traditional Surveillance Paradigms in Early-stage Testicular Germ Cell Tumors? A Case Study in Pre-clinical Relapse Detection Using a Combination Micro-RNA-371a-3p and 372-3p AssayJonathan Huynh, Adam Levin, Vincent D'Andrea, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 19, 2015
Follow-Up Management of Patients With Testicular Cancer: A Multidisciplinary Consensus-Based ApproachClair J Beard, Shilpa Gupta, Robert J Motzer, et al.
Investigational New Drugs|May 24, 2007
Phase II trial of ixabepilone in patients with cisplatin-refractory germ cell tumorsDarren R Feldman, G Varuni Kondagunta, Michelle S Ginsberg, et al.
European Urology Open Science|August 18, 2025
Pathologic and Oncologic Outcomes of Patients Undergoing Orchiectomy After Chemotherapy for Advanced Testicular Germ Cell TumorsViranda H Jayalath, Fady Baky, Samuel A Gold, et al.
Cancer|April 23, 2013
Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and olderDarren R Feldman, Martin H Voss, Erin P Jacobsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysisDarren R Feldman, Joel Sheinfeld, Dean F Bajorin, et al.
Urology|August 11, 2024
Long-term Outcomes of Regressed or "Burnt Out" Primary Testicular Germ Cell TumorsFady J Baky, Nicole Liso, Brandon Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2006
Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumorsG Varuni Kondagunta, Jennifer Bacik, Joel Sheinfeld, et al.
Urology|February 8, 2018
Clinical Outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy SpecimenCatherine M Dowling, Melissa Assel, John E Musser, et al.
Pageof 12